RSS FeedRSS Feed

Ikaria News


IKARIA® TO PRESENT AT BIOTECH SHOWCASE™ 2014

January 7, 2014 Read more

 

MADISON DEARBORN PARTNERS TO ACQUIRE IKARIA®

December 24, 2013 Read more

 

IKARIA® SHAREHOLDERS LED BY NEW MOUNTAIN CAPITAL REACH AGREEMENT TO SPLIT IKARIA INTO TWO COMPANIES

December 24, 2013 Read more

 

IKARIA® TO PRESENT AT 2013 BIO BUSINESS FORUM AND INTERNATIONAL CONVENTION

April 16, 2013 Read more

 

FDA CLEARS INOMAX® DSIR TO CONNECT WITH HOSPITAL HEALTH INFORMATION SYSTEMS
-- INOMAX® Drug-Delivery Systems Now Compatible With 60 Respiratory Care Devices --

November 13, 2012 Read more

 

See more press releases

IKARIA® TO PRESENT AT WEDBUSH SECURITIES 2012 LIFE SCIENCES MANAGEMENT ACCESS CONFERENCE

August 7, 2012 Read more

 

IKARIA® TO PRESENT AT 2012 BIO INTERNATIONAL CONVENTION

June 12, 2012 Read more

 

LUCASSIN® APPROVED IN AUSTRALIA

April 23, 2012 Read more

 

IKARIA® APPOINTS CHIEF MEDICAL OFFICER

April 11, 2012 Read more

 

FDA CLEARS EXPANDED COMPATIBILITY FOR INOMAX® DRUG-DELIVERY SYSTEMS
– INOMAX® DS and INOMAX® DSIR Now Compatible with Nearly 60 Respiratory Care Devices –

March 21, 2012 Read more

 

IKARIA® COMPLETES PATIENT ENROLLMENT IN PIVOTAL PHASE III TRIAL FOR BRONCHOPULMONARY DYSPLASIA
– Enrollment Concludes Ahead of Schedule –

February 27, 2012 Read more

 

IKARIA® TO PRESENT AT 14TH ANNUAL BIO CEO & INVESTOR CONFERENCE

February 6, 2012 Read more

 

FDA GRANTS ORPHAN DRUG DESIGNATION TO IKARIA® FOR USE OF INHALED NITRIC OXIDE IN PULMONARY ARTERIAL HYPERTENSION
– Investigational New Drug Application Submitted –

January 23, 2012 Read more

 

IKARIA® TO PRESENT AT BIOTECH SHOWCASE™ 2012

January 4, 2012 Read more

 

IKARIA® COMMENCES GLOBAL REGISTRATION TRIAL FOR BIOABSORBABLE CARDIAC MATRIX
– PRESERVATION I Investigates Novel Device for Cardiac Remodeling and Congestive Heart Failure –

January 3, 2012 Read more

 

IKARIA® ISSUES NOTICE OF COMPLETED REMEDIATION FOR INOMAX® DS DRUG-DELIVERY SYSTEM

December 22, 2011 Read more

 

IKARIA® TO PRESENT AT 2011 LAZARD CAPITAL MARKETS HEALTHCARE CONFERENCE

November 8, 2011 Read more

 

 

IKARIA® TO PRESENT AT 2011 BIO INVESTOR FORUM

October 18, 2011 Read more

 

IKARIA® NAMES NEW CHIEF FINANCIAL OFFICER

October 11, 2011 Read more

 

IKARIA® CEO DANIEL TASSÉ ELECTED TO PhRMA BOARD OF DIRECTORS

September 22, 2011 Read more

 

IKARIA® TO PRESENT AT STIFEL NICOLAUS 2011 HEALTHCARE CONFERENCE

August 31, 2011 Read more

 

IKARIA® TO PRESENT AT 2011 WEDBUSH LIFE SCIENCES MANAGEMENT ACCESS CONFERENCE

August 9, 2011 Read more

 

FDA CLEARS EXPANDED COMPATIBILITY FOR INOMAX DRUG-DELIVERY SYSTEMS
-- INOMAX® DS and INOMAX® DSIR NOW COMPATIBLE WITH 51 RESPIRATORY CARE DEVICES --

August 1, 2011 Read more

 

IKARIA® CEO DANIEL TASSÉ ELECTED TO HEALTH SECTION OF BIO'S BOARD OF DIRECTORS

June 28, 2011 Read more

 

IKARIA® TO PRESENT AT 2011 BIO BUSINESS FORUM AND INTERNATIONAL CONVENTION

June 21, 2011 Read more

 

IKARIA® LAUNCHES NEXT-GENERATION DRUG-DELIVERY SYSTEM

April 11, 2011 Read more

 

IKARIA® INTRODUCES NEXT-GENERATION INOMAX® DRUG-DELIVERY SYSTEM IN AUSTRALIA

March 23, 2011 Read more

 

IKARIA® TO PRESENT AT 31st ANNUAL COWEN AND COMPANY HEALTHCARE CONFERENCE

March 2, 2011 Read more

 

IKARIA® INTRODUCES NEXT-GENERATION DRUG-DELIVERY SYSTEM IN CANADA

February 22, 2011 Read more

 

FDA EXTENDS MARKETING EXCLUSIVITY FOR INOMAX®

January 5, 2011 Read more

 

IKARIA® BEGINS ENROLLMENT OF PIVOTAL TRIAL FOR LUCASSIN®

November 30, 2010 Read more

 

IKARIA® RECALLS INOMAX® DS DRUG-DELIVERY SYSTEM

August 9, 2010 Read more

 

IKARIA® NAMES CHIEF SCIENCE OFFICER

July 15, 2010 Read more

 

IKARIA® NAMES NEW CHIEF FINANCIAL OFFICER

July 8, 2010 Read more

 

IKARIA® APPOINTS CHIEF MEDICAL OFFICER

June 8, 2010 Read more

 

IKARIA® NAMES NEW HEAD OF RESEARCH & DEVELOPMENT

June 1, 2010 Read more

 

IKARIA® ANNOUNCES ELECTION OF HOWARD H. PIEN TO BOARD OF DIRECTORS

April 14, 2010 Read more

 

IKARIA® ACQUIRES NEW DRUG APPLICATION FOR LUCASSIN®

March 30, 2010 Read more

 

$2.5 MILLION GIFT AIMS TO HELP CHILDREN SURVIVE AND THRIVE

March 24, 2010 Read more

 

IKARIA® RECEIVES AWARD FOR EXCELLENCE BY NEW JERSEY BUSINESS & INDUSTRY ASSOCIATION

October 21, 2009 Read more

 

IKARIA® NAMES NEW CHAIRMAN

October 19, 2009 Read more

 

IKARIA® TO IN-LICENSE WORLDWIDE RIGHTS TO INVESTIGATIONAL PORTFOLIO FROM FIBREX MEDICAL

August 10, 2009 Read more

 

IKARIA® TO IN-LICENSE BIOLINERx'S BL-1040

July 6, 2009 Read more

 

FDA ACCEPTS FINAL SECTION OF NDA FILING FOR LUCASSIN®

Jun 12, 2009 Read more

 

IKARIA® TO PRESENT AT 27th ANNUAL JPMORGAN HEALTHCARE CONFERENCE

Jan 8, 2009 Read more

 

IKARIA® NAMED PRIVATE COMPANY OF THE YEAR BY NEW JERSEY TECHNOLOGY COUNCIL

Nov 21, 2008 Read more

 

INHALED NITRIC OXIDE DATA PRESENTED AT EUROPEAN ACADEMY OF PEDIATRICS MEETING

Oct 25, 2008 Read more

 

IKARIA® STRENGTHENS EXECUTIVE LEADERSHIP TEAM
Head of Engineering and Operations Appointed.

Oct 2, 2008 Read more

 

IKARIA® ACQUIRES NORTH AMERICAN RIGHTS TO LUCASSIN® FROM ORPHAN THERAPEUTICS
No Currently Approved Drugs to Treat Hepatorenal Syndrome Type 1 in U.S.

Sept. 2, 2008 Read more

 

IKARIA® STRENGTHENS COMMERCIAL OPERATIONS AND HUMAN RESOURCES LEADERSHIP
Appoints Stephen Ross Senior Vice President of Commercial Operations and James Briggs Senior Vice President of Human Resources.

Aug. 25, 2008 Read more

 

IKARIA® RECEIVES FDA ORPHAN DRUG DESIGNATION FOR INHALED CARBON MONOXIDE FOR DELAYED GRAFT FUNCTION IN SOLID ORGAN TRANSPLANTS

July 28, 2008 Read more

 

IKARIA'S INOFLO (NITRIC OXIDE) FOR INHALATION APPROVED IN JAPAN
Ikaria to Market and Distribute INOflo via Partnership with Air Water Incorporated and Sumitomo Seika Chemicals

July 21, 2008 Read more

 

IKARIA® STRENGTHENS RESEARCH & DEVELOPMENT TEAM
Appoints Dr. Deborah Petrowsky Vice President of Medical Affairs and Dr. Steven Knapp Vice President of Regulatory Affairs

July 1, 2008 Read more

 

IKARIA® INTRODUCES DR. MICHAEL COOREMAN AS VICE PRESIDENT OF TRANSLATIONAL MEDICINE
Translational Medicine Department Strengthens Research & Development Team

June 24, 2008 Read more

 

IKARIA'S INOFLO (NITRIC OXIDE) FOR INHALATION TO BE OFFICIALLY APPROVED IN JAPAN

June 18, 2008 Read more

 

IKARIA® COMPLETES DOSING OF PHASE 1A CLINICAL STUDY FOR IK-1001 (SODIUM SULFIDE) FOR INJECTION

May 19, 2008 Read more

 

LOTA ZOTH ELECTED TO IKARIA® BOARD AND NAMED AUDIT COMMITTEE CHAIR

Jan. 22, 2008 Read more

 

IKARIA® WINS SECOND CONSECUTIVE AARC ZENITH AWARD
at 53rd International Respiratory Congress

Jan. 17, 2008 Read more

 

IKARIA® APPOINTS DANIEL TASSÉ AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
Former CEO David Shaw Named Executive Chairman and Chairman of the Board.

Jan. 9, 2008 Read more

 

IKARIA® TO PRESENT AT 26th ANNUAL JPMORGAN HEALTHCARE CONFERENCE

Jan. 3, 2008 Read more

 

IKARIA'S INOMAX (NITRIC OXIDE) FOR INHALATION APPROVED IN AUSTRALIA
Expands global reach of Ikaria with approval of first pharmaceutical gas in Australia to help newborns who suffer from hypoxic respiratory failure.

November 27, 2007 Read more

 

IKARIA® NAMES EXECUTIVE VICE PRESIDENT OF RESEARCH AND DEVELOPMENT

October 1, 2007 Read more

 

IKARIA® FOUNDING SCIENTIST NAMED 2007 MACARTHUR FELLOW

September, 26, 2007 Read more

 

NEW STUDY SHOWS PROMISE FOR HYDROGEN SULFIDE IN REDUCING HEART-ATTACK DAMAGE, IKARIA® ANNOUNCES Study led by Albert Einstein College of Medicine researchers published in major scientific journal

September 25, 2007 Read more

 

MATTHEW BENNETT JOINS IKARIA® AS VICE PRESIDENT AND GENERAL COUNSEL

July 23, 2007 Read more

 

DAVID SHAW TO SERVE AS PRESIDENT OF IKARIA® AND INO THERAPEUTICS

May 2, 2007 Read more

 

IKARIA® AND INVESTOR GROUP CLOSE TRANSACTION TO ACQUIRE INO THERAPEUTICS FROM LINDE IN $670 MILLION CASH AND STOCK MERGER, CREATING A WORLD LEADER IN CRITICAL CARE THERAPEUTICS

March 28, 2007 Read more

 

IKARIA® ANNOUNCES IN-LICENSING OF "THYRONAMINE TECHNOLOGY" FROM THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO AND OREGON HEALTH & SCIENCE UNIVERSITY

February 25, 2007 Read more

 

INO THERAPEUTICS WINS ZENITH AWARD

December, 2006 Read more